Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Total Debt (2021 - 2024)

Standard Biotools (LAB) has disclosed Total Debt for 7 consecutive years, with $54.9 million as the latest value for Q3 2024.

  • On a quarterly basis, Total Debt rose 471.12% to $54.9 million in Q3 2024 year-over-year; TTM through Sep 2024 was $54.9 million, a 471.12% increase, with the full-year FY2023 number at $57.9 million, up 607.15% from a year prior.
  • Total Debt was $54.9 million for Q3 2024 at Standard Biotools, roughly flat from $54.7 million in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $57.9 million in Q4 2023 to a low of $8.2 million in Q4 2022.
  • A 4-year average of $21.4 million and a median of $10.2 million in 2022 define the central range for Total Debt.
  • Peak YoY movement for Total Debt: decreased 18.46% in 2022, then soared 607.15% in 2023.
  • Standard Biotools' Total Debt stood at $10.0 million in 2021, then dropped by 18.46% to $8.2 million in 2022, then skyrocketed by 607.15% to $57.9 million in 2023, then fell by 5.23% to $54.9 million in 2024.
  • Per Business Quant, the three most recent readings for LAB's Total Debt are $54.9 million (Q3 2024), $54.7 million (Q1 2024), and $57.9 million (Q4 2023).